April 8, 2021

Partial Clinical Hold of Phase Ib Clinical Trial of RVU120 (SEL120) by the FDA in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Year

2021

Assets in this page

Download assets

  • pdf file

    Current Report ESPI 09/2021

    Download